Position in PFE
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,242,696
-$474,396 QoQ
Shares Held
51,607
-15.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,195
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWLAND CAPITAL MANAGEMENT LLC holds $45,192,590 across 9 Drug Manufacturers - General names. PFE ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
87,734 | $22,281,803 | |
| 2 | ABBV |
AbbVie Inc.
|
29,636 | $7,457,603 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,824 | $5,888,384 | |
| 4 | LLY |
ELI LILLY & Co
|
3,121 | $3,743,421 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
11,420 | $1,442,802 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
22,408 | $1,291,148 | |
| 7 | AMGN |
Amgen Inc
|
3,560 | $1,289,147 | |
| 8 | PFE |
Pfizer Inc
This page
|
51,607 | $1,242,696 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,242,696 | 51,607 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,717,092 | 61,150 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,424,130 | 57,194 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,358,160 | 53,303 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,040,211 | 42,913 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,223,491 | 48,283 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,658,151 | 62,501 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,717,212 | 59,337 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,727,597 | 61,744 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,752,162 | 63,141 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,959,792 | 68,072 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $2,398,854 | 72,320 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $2,732,476 | 74,495 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $3,058,286 | 74,958 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $4,110,831 | 80,227 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $3,436,341 | 78,527 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $3,863,776 | 73,694 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $3,203,165 | 61,873 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $3,522,923 | 59,660 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $2,559,095 | 59,500 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $2,353,907 | 60,110 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,249,883 | 62,100 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,150,955 | 58,434 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $2,152,709 | 58,657 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,932,800 | 59,107 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $1,952,228 | 59,811 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||